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Targeted genome engineering with RNA-guided engineered 
nucleases (RGENs) repurposed from the clustered regularly interspaced 
short palindromic repeat (CRISPR) systems has recently received 
significant attention because of their simple design and preparation. 
Although, RGENs-mediated genome editing has been successfully 
ii
performed in cultured cells and model organisms, developing a highly 
efficient and specific  CRISPR-based genome editing platform is still a 
major challenge in this area. 
In this study, I develop and optimize the new CRISPR-based 
genome editing platforms and investigate their target specificities. First, 
I present delivery of RGEN RNPs in plant cells. RGEN RNPs enabled 
DNA-free genome editing in plant cells at high frequencies up to 44%. 
Whole plants were successfully regenerated from gene-edited cells and 
no apparent off-target mutations were detected in these mutants.  This 
method may reduce the likelihood of DNA insertion and potential 
off-target effects and alleviate the concerns related to genetically 
modified plants. Second, I optimize the Cpf1-mediated genome editing 
system and investigate its target specificity. CRISPR-Cpf1 system 
induced targeted genome modification efficiently in human cells. 
Mismatched crRNAs test and genome-wide off-target analysis showed 
that this nuclease yielded DNA cleavages at the target site in a highly 
specific manner. These results indicate that CRISPR-Cpf1 is suitable for 
precision genome editing and will be a good option for RNA-guided 
genome editing.
  
Keywords : Genome engineering, Programmable nucleases, Clustered 
Regularly Interspaced Short Palindromic Repeats (CRISPR),  
RNA-guided Endonucleases (RGENs), Cpf1




TABLE OF CONTENTS iii
LIST OF FIGURES vi
LIST OF TABLES viii
LIST OF ABBREVIATIONS ix
CAHPTER 1. DNA-free genome editing in plants with 
preassembled CRISPR-Cas9 ribonucleoproteins 
INTRODUCTION 2
MATERIALS AND METHODS
       1. Cas9 protein and guide RNA preparation 6
       2. Construction of RGEN-encoding plasmids 6
       3. Protoplast culture and isolation 7
       4. Protoplast transfection 8
       5. Genomic DNA isolation 9
       6. T7E1 assay 9
       7. Targeted deep sequencing 10 
iv
       8. RGEN-RFLP 10
       9. Protoplast regeneration 11
RESULTS
     1. Targeted gene modification in plant protoplasts using 
        RGEN RNPs
       a. Targeted gene disruption in protoplasts of plants 14
       b. Analysis of off-target effects 20
       c. Comparison of the delivery methods of RGEN   22
     2. Targeted gene knockout and whole plant regeneration 
        in lettuce using RGEN RNPs
       a. Generation of BIN2 gene knockout lettuce 26
       b. Analysis of off-target effects in regenerated plantlets 33
       c. Germline transmission of mutant-alleles 38
DISCUSSION 44
CHAPTER 2. Genome-wide analysis reveals specificities of Cpf1 




       1. Cas9 and Cpf1 ribonucleoproteins 53
       2. Plasmids encoding Cpf1 and crRNAs 54
       3. Cell culture and transfection conditions 54
       4. Isolation of mutant clones 55
RESULTS
     1. Genome editing in human cells using Cpf1 system
       a. Optimization of Cpf1 system 56
       b. Isolation of mutant clones 65
       c. Comparison of the mutation frequencies obtained 
          with Cpf1 and SpCas9   67
     2. Analysis of target specificity of Cpf1
       a. Analysis of target specificity of Cpf1 using 
          mismatched crRNAs 71
       b. Genome-wide target specificity of Cpf1 74
       c. Analysis of target specificity of Cpf1 using 
          truncated crRNAs 82
     
DISCUSSION 84
REFERENCES 88
ABSTRACT IN KOREAN 102
vi
List of Figures 
 
Figure 1. Scheme for RGEN RNP-mediated genome editing in 
         plant protoplasts 16
Figure 2. RGEN RNP-mediated gene modification in plant 
         protoplasts of Arabidopsis thaliana 17
Figure 3. RGEN RNP-mediated gene modification in plant 
         protoplasts of Nicotiana attenuata and Oryza sativa 18
Figure 4. A Time-course analysis of gene modification efficiency 19
Figure 5. Targeted deep sequencing of potential off-target sites 
         of the PHYB and BRI1 gene-specific sgRNAs 21
Figure 6. Mutation frequencies obtained with plasmid transfection
         and RNP delivery 24
Figure 7. The target sequence in the BIN2 gene 28
Figure 8. Microcalli regenerated from the RGEN RNP-
         transfected cells 29
Figure 9. Genotyping of microcalli 30
Figure 10. Whole plants regenerated from genome-edited calli 32
Figure 11. Genotyping of T1 plantlets derived from T0-12 mutant 40
Figure 12. Genotyping of T1 plantlets derived from T0-24 mutant 42
Figure 13. Genome editing with Cpf1 plasmids and crRNA-
          encoding amplicon 59
Figure 14. DNA constructs for Cpf1-meidated genome editing 60
Figure 15. Condition optimization of Cpf1-mediated genome editing 61
vii
Figure 16. Comparison of crRNA delivery methods 62
Figure 17. Genome editing using plasmids encoding Cpf1 orthologs 
          and crRNAs 63
Figure 18. Isolation of Cpf1-mediated mutant clones 66
Figure 19. On-target indel rates obtained with AsCpf1, LbCpf1, 
          and SpCas9 at 10 endogenous sites 70
Figure 20. Analysis of target specificity of Cpf1 with 
          mismatched crRNAs 72
Figure 21. Genome-wide Circos plots of DNA cleavage scores 
          obtained with AsCpf1, LbCpf1 and SpCas9 76
Figure 22. The number of in vitro cleavage site 78
Figure 23. Validation of in vitro cleavage sites by 
          targeted deep sequencing 79
Figure 24. Cpf1-mediated gene editing at target sites 
          containing non-canonical PAM sequences 80
Figure 25. Analysis of target specificity of Cpf1 with 
          truncated crRNAs 83
viii
List of Tables
Table 1. Oligonucleotides used for in vitro transcription template 12
Table 2. Oligonucleotides used for T7E1 assay 13
Table 3. Number of potential off-target sites of BIN2 gene-
        specific sgRNAs in the lettuce genome 34
Table 4. Indel frequencies at the on-target and 91 potential 
        off-target sites in regenerated plantlets 35




CRISPR Clustered regularly interspaced palindromic repeats
crRNA CRISPR RNA
Cpf1 CRISPR from Prevotella and Francisella 1
DSB Double-strand break
HEK Human embryonic kidney
HR Homologous recombination 
NHEJ Non-homologous end-joining
PAM Protospacer adjacent motif
PCR Polymerase chain reaction
PEG Polyethylene glycol
RFLP Restriction fragment length polymorphism   
RGEN         RNA-guided engineered nuclease
RNP Ribonucleoprotein
sgRNA Single-guide RNA
T7E1 T7 endonuclease 1 
ZFN Zinc-finger nuclease
TALEN Transcription activator-like effector nuclease   
1
Chapter 1. DNA-free genome editing in plants 




Understanding the function of genes and non-coding elements 
is one of the principal challenges in basic researches. To do this, 
gene-targeting (Capecchi, 1989) and siRNAs have been traditionally 
used for knocking-out and regulating the genetic elements. 
Gene-targeting uses homologous recombination between chromosomal 
DNA sequence and exogenously introduced DNA sequence, yielding a 
genetic modification of target site. This method is powerful in some 
systems such as mouse embryonic stem cells and yeasts, but the 
efficiency of gene-targeting is generally low (10-6 to 10-7) in 
eukaryotic cells, hampering the widespread use of this tool. In case of 
siRNAs, siRNAs can only target the genetic elements transcribed, 
indicating that function of genetic elements such as DNA binding 
motifs for transcription factors can’t be interrogated with this method. 
Besides, siRNAs induce a gene knockdown non-specifically in some 
cases (Fedorov et al., 2006; Jackson et al., 2006). 
Recently, programmable nucleases have emerged as a game 
changer in the field of genome engineering (Kim and Kim, 2014). 
Programmable nuclease is a kind of artificial enzyme, which can 
produce DNA double strand breaks (DSBs) at the desired site in the 
genome. DSBs generated by these nucleases boost cellular DNA repair 
mechanisms such as error-prone non-homologous end joining (NHEJ) 
and homology-directed repair (HDR) in the presence of a donor DNA, 
yielding a targeted gene modification at a high frequency. The three 
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most commonly used programmable nucleases are zinc-finger nucleases 
(ZFNs) (Bibikova et al., 2002; Kim et al., 1996; Lee et al., 2010; 
Urnov et al., 2005; Urnov et al., 2010), transcription activator-like 
effector nucleases (TALENs) (Boch et al., 2009; Christian et al., 2010; 
Kim et al., 2013; Miller et al., 2011; Moscou and Bogdanove, 2009) 
and RNA-guided engineered nucleases (RGENs) repurposed from the 
bacterial clustered regularly interspaced short palindromic repeat 
(CRISPR)–Cas (CRISPR-associated) system (Cho et al., 2013a; Cong et 
al., 2013; Hwang et al., 2013; Jiang et al., 2013; Jinek et al., 2012; 
Jinek et al., 2013; Mali et al., 2013).
ZFN is a fusion protein composed of zinc-finger protein (ZFP) 
and nuclease domain of Fok I type IIS restriction endonuclease (Kim et 
al., 1996). Target specificity of nuclease is determined by ZFP and 
nuclease domain of Fok I produces DNA cleavages at the site 
recognized by ZFP. ZFP consists of zinc-finger modules, and each 
zinc-finger recognizes a specific 3-bp of DNA sequence. In case of 
TALENs, DNA cleavage activity of these proteins is triggered from the 
nuclease domain of Fok I like ZFNs, but transcription activator-like 
effectors (TALEs) determine the target site instead of ZFP. TALEs 
recognize the DNA sequence at a 1-bp resolution (Boch et al., 2009; 
Moscou and Bogdanove, 2009), which makes it easy to design a target 
site, expanding the design density of programmable nucleases. 
Meanwhile, RGENs recognize and cleave the target DNA in an entirely 
different way. RGENs consist of Cas9 protein and guide RNA. Guide 
RNA recognizes a target site by Watson-Crick base pairing and DNA 
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cleavages at the target site are triggered by Cas9 protein (Jinek et al., 
2012). Target sites of RGENs can be easily replaced by preparing a 
new guide RNA only, which makes the breaking down of barriers of 
genome engineering resulting in the CRISPR Craze in biological 
sciences (Pennisi, 2013).
In the field of plant science, several groups independently 
reported that RGEN-mediated genome editing could induce targeted 
genome modifications in plant genomes at a high frequency (Li et al., 
2013; Nekrasov et al., 2013; Shan et al., 2013). Compared with 
classical approaches to genetic modifications in plants, including a 
transferring the whole gene, random mutagenesis with chemicals and 
radiation and breeding, CRISPR-based technology enables a precise 
genome engineering because RGENs cut a predetermined site and 
induce small indels that are indistinguishable from naturally occurring 
genetic variations. RGEN-mediated genome editing also enables the 
rapid alteration of plants. Genome-editing with RGENs in plant systems 
has been established as a powerful tool for interrogating the gene 
function in academic researches.
Now, RGEN-mediated genome editing has drawn attention from 
not only basic research, but plant biotechnology and agriculture as a 
tool for improving crops. RGENs make it possible to generate crops 
that have new traits more straightforwardly. But, there is an unclear 
issue related to a regulatory approval of genetically modified crops 
obtained by CRISPR technology. The U.S. Department of Agriculture 
(USDA)’s rule has so far focused on whether genome-edited plants 
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contain foreign DNA and the USDA has recently decided that 
genome-edited plants obtained by transient transfection of plasmid DNA 
which encodes an expression cassette of programmable nucleases are 
exempted from genetically modified organism (GMO) legislation (Jones, 
2015; Pennisi, 2016; Waltz, 2016). In case of EU and other regions, 
they have postponed its own decision. However, delivery of 
non-integrating plasmids into plant cells still has a matter of debate. In 
human cell experiments, several groups reported that a partial sequence 
of plasmid DNA could be inserted at the on-target and off-target sites 
of RGEN (Cradick et al., 2013; Fu et al., 2013). To rule out a little 
possibility of DNA insertion, delivery of preassembled CRISPR-Cas9 
ribonucleproteins (Kim et al., 2014b) in plant cells might be a good 
approach to solve this problem.
Here, I design a platform for plant genome editing using 
preassembled CRISPR-Cas9 ribonucleoproteins (Kim and Kim, 2016; 
Woo et al., 2015) and show that RGEN RNP induce targeted genome 
modification at a high frequency and whole plants are successfully 
regenerated from RGEN RNP-transfected protoplasts. I propose that this 
method may circumvent regulatory issues related to genetically modified 




1. Cas9 protein and guide RNA preparation
Cas9 protein tagged with HA epitope and nuclear localization 
signal was purchased from ToolGen, Inc. (South Korea). Purified Cas9 
protein was stored against 20 mM HEPES (pH 7.5), 150 mM KCl, 
1mM DTT and 10% glycerol at -20℃. Concentration of cas9 protein 
was adjusted to 10 mg/ml for ready to use. DNA templates for in vitro 
transcription of sgRNA were generated by oligo extension using 
phusion polymerase (New England BioLabs) and T7 RNA polymerase 
(New England BioLabs) was used to run-off in vitro transcription. For 
eliminating in vitro transcription template, DNase1 was treated to the 
reaction mixture after transcription. Transcribed sgRNAs were purified 
with MG PCR Product purification SV (Macrogen) and quantified by 
spectrometry. 
2. Construction of RGEN-encoding plasmids
Cas9 expression plasmid for plant genome editing was modified 
from the human codon optimized p3s-CMV-hCas9 vector. For 
optimization, promoter was replaced to 35S promoter and BGH 
polyadenylation signal was replaced to 35S terminator sequence. sgRNA 
vector for protoplast test was designed to Arabidopsis U626 
promoter-driven transcription. RGEN-encoding plasmids for protoplast 
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transfection were prepared with NucleoBond Xtra Midi kit 
(Macherey-Nagel). 
3. Protoplast culture and isolation
Protoplasts were isolated as previously described from 
Arabidopsis, rice and lettuce. Initially, Arabidopsis (Arabidopsis thaliana) 
ecotype Columbia-0, rice (Oryza sativa L.) cv. Dongjin, and lettuce 
(Lactuca sativa L.) cv Cheongchima seeds were sterilized in a 70% 
ethanol, 0.4% hypochlorite solution for 15 min, washed three times in 
distilled water, and sown on 0.5× Murashige and Skoog solid medium 
supplemented with 2% sucrose. The seedlings were grown under a 16 
h light (150 μmol m−2 s−1) and 8 h dark cycle at 25 °C in a growth 
room. For isolation of protoplasts, the leaves of 14 d Arabidopsis 
seedlings, the stem and sheath of 14 d rice seedlings, and the 
cotyledons of 7 d lettuce seedlings were digested with enzyme solution 
(1.0% cellulase R10, 0.5% macerozyme R10, 0.45 M mannitol, 20 mM 
MES [pH 5.7], CPW solution21) during incubation with shaking (40 
r.p.m.) for 12 h at 25 °C in darkness and then diluted with an equal 
volume of W5 solution. The mixture was filtered before protoplasts 
were collected by centrifugation at 100g in a round-bottomed tube for 
5 min. Re-suspended protoplasts were purified by floating on a CPW 
21S (21% [w/v] sucrose in CPW solution, pH 5.8) followed by 
centrifugation at 80g for 7 min. The purified protoplasts were washed 
with W5 solution and pelleted by centrifugation at 70g for 5 min. 
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Finally, protoplasts were re-suspended in W5 solution and counted 
under the microscope using a hemocytometer. Protoplasts were diluted 
to a density of 1 × 106 protoplasts/ml of MMG solution (0.4 M 
mannitol, 15 mM MgCl2, 4 mM MES [pH 5.7]). In the case of 
tobacco protoplasts, 3-week-old Nicotiana attenuata leaves grown in B5 
media were digested with enzymes (1% cellulose R10, 0.25% 
macerozyme R10, 0.5 M Mannitol, 8 mM CaCl2, 5 mM MES [pH 
5.7], 0.1% BSA) for 5 h at 25 °C in darkness. Subsequently, 
protoplasts were washed with an equal volume of W5 solution twice. 
To obtain intact protoplasts, N. attenuata protoplasts in W5 solution 
were applied to an equal volume of 21% sucrose gradient followed by 
swing-out centrifugation at 50g for 5 min. The intact protoplasts were 
re-suspended in W5 solution and stabilized at least for 1 h at 4 °C 
before PEG-mediated transfection.
4. Protoplast transfection
PEG-mediated RNP transfections were performed as previously 
described. Briefly, to introduce DSBs using an RNP complex, 1 × 105 
protoplast cells were transfected with Cas9 protein (10–60 μg) premixed 
with in vitro–transcribed sgRNA (20–120 μg). Prior to transfection, 
Cas9 protein in storage buffer (20 mM HEPES pH 7.5, 150 mM KCl, 
1 mM DTT, and 10% glycerol) was mixed with sgRNA in 1× NEB 
buffer 3 and incubated for 10 min at room temperature. A mixture of 
1 × 105 protoplasts (or 5 × 105 protoplasts in the case of lettuce) 
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re-suspended in 200 μl MMG solution was gently mixed with 5–20 μl 
of RNP complex and 210 μl of freshly prepared PEG solution (40% 
[w/v] PEG 4000; Sigma No. 95904, 0.2 M mannitol and 0.1 M 
CaCl2), and then incubated at 25 °C for 10 min in darkness. After 
incubation, 950 μL W5 solution (2 mM MES [pH 5.7], 154 mM NaCl, 
125 mM CaCl2 and 5 mM KCl) was added slowly. The resulting 
solution was mixed well by inverting the tube. Protoplasts were pelleted 
by centrifugation at 100g for 3 min and re-suspended gently in 1 ml 
WI solution (0.5 M mannitol, 20 mM KCl and 4 mM MES (pH 5.7)). 
Finally, the protoplasts were transferred into multi-well plates and 
cultured under dark conditions at 25 °C for 24–48 h. Cells were 
analyzed one day after transfection.
5. Genomic DNA isolation
Genomic DNA of protoplast and microcalli was isolated with 
DNeasy Plant Mini Kit (Qiagen). Genomic DNA of cotyledon derived 
from T1 plantlet was isolated with ZR Plant/Seed DNA MiniPrep 
(Zymo Research). 
6. T7E1 assay
RGEN target site was amplified from purified genomic DNA 
by PCR. The target site contained-amplicon was denatured at 95℃ and 
cooled down to a room temperature slowly using a thermal cycler. 
Reannealed PCR amplicon was incubated with T7E1 (ToolGen, Inc.) in 
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1× NEB buffer 2 condition for 30 min at 37’C. The reaction mixture 
was analyzed by gel electrophoresis. DNA band intensities were 
calculated using densitometry. 
7. Targeted deep sequencing 
RGEN-target site and potential off-target sites were amplified 
from genomic DNA. Indices and sequencing adaptors were added by 
additional PCR. Paired-end sequencing was performed with a prepared 
amplicon library and MiSeq reagent kit v2 (300-cycles) was used for 
running. Raw fastq files were joined and indel reads were counted 
using a bioinformatic tool. 
8. RGEN-RFLP
RGEN-RFLP assay was performed as previously described. In 
brief, 300 ng of PCR product was incubated with cas9 protein (1 μg) 
and sgRNA (750 ng) in a reaction volume of 10 µl at 37 °C for 60 
min. NEB buffer 3 was used for RGEN-mediated cleavage. 4 μg of 
RNase A was used to remove the sgRNA after in vitro cleavage 
reaction. The reaction mixture was purified MG PCR Product 
purification SV (Macrogen) and purified sample was analyzed by 




RNP-transfected protoplasts were re-suspended in 0.5× B5 
culture medium supplemented with 375 mg/l CaCl2•2H2O,18.35 mg/l 
NaFe-EDTA, 270 mg/l sodium succinate, 103 g/l sucrose, 0.2 mg/l 
2,4-dichlorophenoxyacetic acid (2,4-D), 0.3 mg/l 6-benzylaminopurine 
(BAP) and0.1 g/l MES. The protoplasts were mixed with a 1:1 solution 
of 0.5× B5 medium and 2.4% agarose to a culture density of 2.5 × 
105 protoplasts/ml. The protoplasts embedded in agarose were plated 
onto 6-well plates, overlaid with 2 ml of liquid 0.5× B5 culture 
medium, and cultured at 25 °C in darkness. After 7 days, the liquid 
medium was replaced with fresh culture medium. The cultures were 
transferred to the light (16 h light [30 μmol m−2 s−1] and 8 h 
darkness) and cultured at 25 °C. After 3 weeks of culture, micro-calli 
grown to a few millimeters in diameter were transferred to MS 
regeneration medium supplemented with 30 g/l sucrose, 0.6% plant 
agar, 0.1 mg/l α-naphthalaneacetic acid (NAA), 0.5 mg/l BAP. 
Induction of multiple lettuce shoots was observed after about 4 weeks 
on regeneration medium.
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Table 1. Oligonucleotides used for in vitro transcription template.
13
Table 2. Oligonucleotides used for T7E1 assay.
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Results
1. Targeted gene modification in plant protoplasts using 
RGEN-RNPs  
a. Targeted gene disruption in protoplasts of plants 
In the previous studies, RGEN-mediated genome editing was 
achieved using delivery vectors such as A. tumefaciens and plasmid 
DNA (Li et al., 2013; Nekrasov et al., 2013; Shan et al., 2013). These 
methods have some possibility of insertion of DNA fragments at both 
on-target and off-target sites. To rule out the possibility of inserting 
recombinant DNA in the host genome, RGEN RNP-mediated plant 
genome editing system was designed (Figure 1). To test whether 
PEG-mediated transfection of RGEN RNP can induce targeted gene 
modification, sgRNA targeting the PHYTOCHROME B (PHYB) gene 
was designed and PEG-mediated transfection was performed (Figure 2). 
I measured the gene modification efficiency by the T7E1 assay (Kim et 
al., 2009) and targeted deep sequencing. I found that RGEN RNP 
induced targeted gene modification of the PHYB gene in Arabidopsis 
and indel rates were increased in a dose dependent manner. Mutation 
rates were saturated when 30 μg of cas9 protein and 60 μg of sgRNA 
were used. 
Next, I investigated whether RGEN RNP can induce targeted 
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gene modification in protoplasts of other plants. The RGEN RNPs were 
incubated with protoplasts derived from tobacco (Nicotiana attenuata) 
and rice (Oryza sativa) in the presence of polyethylene glycol (PEG). I 
used both the T7E1 assay and targeted deep sequencing to measure 
mutation frequencies in transfected cells (Figure 3a). Indels were 
detected at the expected position upstream of an NGG 
protospacer-adjacent motif (PAM) (Figure 3b), with frequencies that 
ranged from 8.4% to 44%. These results show that RGEN RNP 
efficiently introduced targeted mutation of plant genome regardless of 
the source of protoplasts. 
Two sgRNAs were designed at the BRASSINOSTEROID 
INSENSITIVE 1 (BRI1) gene and co-transfected into protoplasts of 
Arabidopsis to investigate whether the repair of two concurrent DSBs 
would result in targeted deletion of the intervening sequence. Genomic 
DNA of transfected cells was isolated and target site-contained region 
was amplified by PCR. The PCR product was cloned into TOPO 
cloning vector and sanger sequencing was performed. Sanger sequencing 
showed that a 223-bp DNA sequence was deleted in protoplasts (Figure 
4). Notably, RGEN-induced mutations were detected 24 h after 
transfection, suggesting that RGENs cut target sites immediately after 
transfection and induce mutation before a full cycle of cell division is 
completed (Figure 4a).
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Figure 1. Scheme for RGEN RNP-mediated genome editing in plant 
protoplasts. Plant protoplasts prepared by enzymatic methods are 
transfected with preassembled CRISPR-Cas9 ribonucleoproteins using 
polyethylene glycol (PEG). Target specific gene disruption is introduced 
and genome-edited plants are regenerated from single mutant cells.   
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Figure 2. RGEN RNP-mediated gene modification in plant protoplasts 
of Arabidopsis thaliana. Purified Cas9 protein and PHYB gene-specific 
sgRNA were mixed and RGEN RNP complex were incubated with 
protoplasts derived from Arabidopsis thaliana. Indel rate were analyzed 
by T7E1 assay and targeted deep sequencing. Indel rates are increasing 




(With Hyeran Kim in Institute for Basic Science)
Figure 3. RGEN RNP-mediated gene modification in plant protoplasts 
of Nicotiana attenuata and Oryza sativa. (a) Mutation frequencies 
measured by the T7E1 assay and targeted deep sequencing. (b) Mutant 
DNA sequences induced by RGEN RNPs in plant cells. The RGEN 
target sequences are underlined and the PAM sequences are shown in 





(By Seung Woo Cho in Seoul National University)
Figure 4. A Time-course analysis of gene modification efficiency. (a) A 
time-course analysis of genome editing of the BRI1 gene in A. thaliana 
protoplasts. Indel rate was analyzed by the T7E1 assay. (b) Mutant 
sequence of dual sgRNAs-mediated large deletion. The RGEN target 
sequences are underlined and the PAM sequences are shown in bold. 
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b. Analysis of off-target effects
Next, I investigated whether RGEN RNPs induce DNA 
cleavages at sites highly homologous to the on target site. Potential 
off-target sites of the PHYB gene –specific sgRNAs were searched in 
the Arabidopsis genome using the Cas-OFFinder program (Bae et al., 
2014) and off-target effects were validated by targeted deep sequencing. 
RGEN RNPs did not induce any indels above basal sequencing error 
levels at any sites (Figure 5) despite the high frequency of on-target 
indel rate. This result indicates that RGEN RNPs induce DNA 
cleavages of plant genome in a highly specific manner, in line with 




Figure 5. Targeted deep sequencing of potential off-target sites of the 
PHYB and BRI1 gene-specific sgRNAs. (a) Potential off-target sites of 
PHYB gene specific sgRNA were analyzed by targeted deep 
sequencing. The RGEN target sequences are underlined and the PAM 
sequences are shown in bold. Mismatched nucleotides are shown in 
lower case. (b) Summary of indel rates of PHYB gene on-target site 
and potential off-target sites. 
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c. Comparison of the delivery methods of RGEN
In the previous study, RGEN-mediated plant genome editing 
was achieved by a transient transfection of plamid DNA-encoding Cas9 
gene and sgRNAs (Li et al., 2013; Shan et al., 2013). To compare the 
genome-editing efficiency of RGEN RNP delivery to that of plasmid 
transfection, I designed RGEN-encoding plasmids optimized for plant 
systems. Cas9 expression plasmid was designed to transcribe cas9 gene 
under a 35S promoter and sgRNA vector was designed to Arabidopsis 
U626 promoter-driven transcription. Transfection was performed with 
RGEN-encoding plasmids and RGEN RNPs about the PHYB gene 
target site. Genomic DNA was isolated 72h post-transfection and T7E1 
assay and targeted deep sequencing were performed to measure the 
gene modification efficiencies. I found that RGEN RNP-method induced 
mutations at a high frequency, comparable to those obtained with 
RGEN-encoding plasmids (Figure 6a). Notably, plasmid-derived 
sequences were found at the target site from raw NGS data obtained 
by transfection of RGEN-encoding plasmids, regardless of the amount 
of the plasmids used (Figure 6b). The frequencies of these insertions 
were low (0.06-0.14 % of total mutations) but are likely 
underestimated, because insertions of >50-bp sequences were excluded 
from deep-sequencing analysis. As expected, no plasmid DNA insertions 
were detected at the target site, when preassembled CRISPR-Cas9 
ribonucleoproteins were used. These results indicate that RGEN RNP 
delivery is an effective method for genome engineering in plant systems 
23






Figure 6. Mutation frequencies obtained with plasmid transfection and 
RNP delivery. (a) Indel rates were analyzed by the T7E1 assay and 
targeted deep sequencing. Arrows indicate cleaved DNA bands. (b) 
Inserted sequences were obtained from raw NGS data. Inserted 
sequences were underlined and aligned with Cas9 and sgRNA-encoding 
plasmids. Origins of inserted sequences were indicated in parentheses. 
The PAM sequences are shown in bold and mismatched nucleotides are 
shown in lower case.
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2. Targeted gene knockout and whole plant regeneration 
in lettuce using RGEN-RNPs  
a. Generation of BIN2 gene knockout lettuce
To test whether RGEN RNP methods could be used for 
generating a mutant plant, RGEN RNPs were transfected into 
protoplasts derived form lettuce (Lactuca sativa) to disrupt the lettuce 
homolog of the A. thaliana BRASSINOSTEROID INSENSITIVE 2 
(BIN2) gene (Figure 7). BIN2 gene is a negative regulator in a 
brassinosteroid (BR) signaling pathway (Choe et al., 2002) and 
knocking-out of BIN2 gene is expected to lead lettuce to having more 
tolerance to various abiotic stresses (Koh et al., 2007). RGEN 
RNP-transfected protoplast were seeded onto 6-well plates, and 
maintained in regeneration medium. After 3 to 4 weeks of culture, 
single cell-derived microcalli were regenerated (Figure 8). 
To analyze the genotype of microcalli, I performed RGEN 
RFLP analysis (Kim et al., 2014a). This analysis uses RGEN RNP 
complexes to cut the PCR amplicon harboring the target site. Cutting 
the RGEN target site in vitro leads to 100 % cleavage for wild-type 
clones, 50 % cleavage for monoallelic mutant clones, and no cleavage 
for heterozygous and homozygous biallelic mutant clones. 19 of 35 
samples were identified as wild-type clones and the rest of the samples 
contained mono allelic  mutation or bi-allelic mutation at the target site 
(Figure 9a). The overall mutation frequency in lettuce calli was 46%. 
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To identify the mutated sequence, clonal samples were subjected to 
targeted deep sequencing (Figure 9b,c). The number of base pairs 
deleted or inserted at the target site ranged from −9 to +1, consistent 
with mutagenic patterns observed in human cells (Cho et al., 2013a). 
No apparent mosaicism was detected in these clones, suggesting that 
the RGEN RNP cleaved the target site immediately after transfection 
and induced indels before cell division was completed.
Subsequently, whole plants were regenerated from 
genome-edited calli (Figure 10). Shoot formation was induced from 
protoplast-calli and root-induction was performed onto elongated shoots. 
Regenerated plantlets were transferred and grown in soil. These results 
show that whole plants were successfully regenerated from 
genome-edited protoplasts with RGEN RNP methods.   
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Figure 7. The target sequence in the BIN2 gene. The PAM sequence is 
shown in bold and the guide sequence is underlined.
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(By Woo Je Wook in Advanced Institutes of Convergence Technology)
Figure 8. Microcalli regenerated from the RGEN RNP-transfected cells. 
(a) Cell division after 5 days of protoplast culture (Bar = 100 μm). (b) 
A multicellular colony of protoplast (Bar= 100 μm). (c) 
Agarose-embedded colonies after 4 weeks of protoplast culture. (d) 






Figure 9. Genotyping of microcalli. (a) Genotyping of microcalli with 
RGEN RFLP assay. No cleavage indicates biallelic mutant clone and 50 
% cleavage indicates monoallelic mutant. WT clones show 100 % 
cleavage. (b) Genetic analysis of microcalli by targeted deep 
sequencing. The RGEN target sequence is underlined and the PAM 
sequence is shown in bold. Inserted sequences are shown in lower case. 
A1 indicates allele 1 and A2 indicates allele 2. (c) Summary of 
analyzed data of microcalli.
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(By Woo Je Wook in Advanced Institutes of Convergence Technology)
Figure 10. Whole plants regenerated from genome-edited calli. (a-c) 
Organogenesis and shoot formation from protoplast-derived calli. Wild 
typd, #28. Heterozygous bi-allelic mutant, #24. Homozygous bi-allelic 
mutant, #30. (d) In vitro shoot proliferation and development. (e) 
Elongation and growth of shoots in MS culture medium free of PGR. 
(f) Root induction onto elongated shoots. (g) Acclimatization of 
plantlets. (h, i) Regenerated plants.
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b. Analysis of off-target effects in regenerated plantlets
To evaluate whether the BIN2-specific RGEN induced off 
target mutations in the lettuce genome, potential off-target sites of BIN2 
gene-specific sgRNAs were searched in silico using the Cas-OFFinder 
program (Bae et al., 2014). Homologous sequences that differed from 
the on-target sequence by up to 5 nucleotides of mismatches were 
searched. The Legassy_V2 database was used as a reference genome 
sequence (Table 3). Genomic DNA was isolated from three 
BIN2-mutated plantlets and targeted deep sequencing libraries were 
generated from these samples by PCR. Some sites were not amplified 
successfully because of a poor quality of reference genome data. Indel 
rates of 92 sites were analyzed and no off-target mutations were 
detected at 91 homologous (Table 4), consistent with  findings in 
human cells that off-target mutations induced by CRISPR RGENs are 
rarely found in a single cell-derived clone (Kim et al., 2015). 
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Table 3. Number of potential off-target sites of BIN2 gene-specific 
sgRNAs in the lettuce genome. Potential RGEN off-target sites were 
identified in the lettuce genome using Cas-OFFinder 
(www.regenome.net). We used the Legassy_V2 database (Genebank: 
AFSA00000000.1) as the reference genome and identified homologous 
sequences that differed from on-target sequences by up to 5 nt. We 
chose a total of 92 sites and performed targeted deep sequencing. Some 
sites were excluded in this analysis because PCR primers couldn’t be 
designed owing to a poor quality of reference genome data or because 




Table 4. Indel frequencies at the on-target and 91 potential off-target 
sites in regenerated plantlets. Indel frequencies were obtained with 
targeted deep sequencing. We couldn’t analyze some potential off-target 
sites because of lack of reference sequence information or poor PCR 
condition.
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c. Germline transmission of mutant-alleles
To test whether RGEN RNP-mediated genome modification is 
germline-transmissible, seeds were obtained from the T0-12 mutants and 
germinated. Two T1 plantlets were obtained and genomic DNA of these 
plantlets was isolated from a cotyledon (Figure 11a). To analyze the 
genotype of T1 plantlets, I performed RGEN RFLP assay and no 
cleavages of PCR amplicons were detected about the T0-12 mutant and 
two T1 plantlets, indicating that T1 plantlets were bi-allelic mutants like 
the T0-12 mutant (Figure 11b). To compare the sequence of mutant 
alleles, I carried out the sanger sequencing of PCR products which 
contained the BIN2 target site. The result obtained with T1 plantlets 
showed that 1-bp insertion was introduced at the cleavage site of 
BIN2-targeting RGEN and these plantlets were homozygous bi-allelic 
mutants. This result was in agreement with the result obtained with the 
T0-12 mutant, indicating that the mutant allele of T0-12 was stably 
transmitted to the next generation (Figure 11c). T1 plantlets were 
additionally obtained from T0-24 mutant, which contained heterozygous 
biallelic mutations. Genotypes of T1 plantlets were analyzed by targeted 
deep sequencing. I found that T1 plantlets derived from the T0-24 
mutant were heterozygous bi-allelic mutants or homozygous bi-allelic 
mutants and frequencies of these mutants were in accordance with the 
law of Mendelian inheritance (Figure 12). In Summary, mutant plants 
could be obtained with RGEN RNP delivery in the first generations at 
a high frequency, and RGEN-mediated mutations were stably transmitted 
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Figure 11. Genotyping of T1 plantlets derived from T0-12 mutant. (a) 
T1 plantlets derived from T0-12 mutant. Scale bars, 1 cm. (b) 
Genotyping of T1 plantlets by RGEN RFLP assay. T1 plantlets show 
bi-allelic mutant pattern. (c) Genotyping of T1 plantlets by Sanger 





Figure 12. Genotyping of T1 plantlets derived from T0-24 mutant. (a) 
Summary table for genotyping analysis of T1 plantlets obtained from 
T0-24 mutant. (b) Mutant sequences of T1 plantlets. Targeted deep 
sequencing was performed and percentages of mutant reads were 
indicated in parentheses. PAM sequence is shown in bold and inserted 
nucleotide is shown in lower case. Guide sequence is underlined. 
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Discussion 
In this study, I designed a new platform for plant genome 
editing via preassembled CRISPR-Cas9 ribonucleoprotiens. RGEN RNPs 
induced targeted genome modifications in plant protoplasts derived from 
Arabidopsis thaliana, tobacco, rice, and lettuce efficiently with 
frequencies that ranged from 8.4% to 44% and whole plants harboring 
the gene-edited allele were successfully regenerated from RGEN 
RNP-transfected lettuce protoplasts at a frequency of 46% in the first 
generation. No apparent off-target effects were detected in the 
regenerated plantlets and I found that gene-edited plants transmitted the 
mutant alleles to the next generation in accordance with the law of 
Mendelian inheritance. 
Now, programmable nucleases including ZFNs, TALENs, and 
RGENs have become an indispensable tool for targeted genome 
engineering in plants (Li et al., 2013; Li et al., 2012; Nekrasov et al., 
2013; Shan et al., 2013; Zhang et al., 2010; Zhang et al., 2013). In 
general, delivery of programmable nucleases in plants have been done 
by transfecting plasmids which encode an expression cassette of 
nucleases or infecting plants with pathogens such as Agrobacterium that 
can transfer a genetic element called T-DNA into the host genome. 
These methods, both depend upon plant cells for transcription and 
translation of these nucleases, so cell-type specific promoters and codon 
optimization are required for the efficient genome editing with 
programmable nucleases in plant cells, demanding a laborious work for 
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each plant species. However, these efforts are unnecessary for RGEN 
RNPs because translation and transcription of nucleases have already 
been completed in vitro. RGEN RNPs cleave the target site 
immediately after transfection and induce targeted genome modification 
at early time-point (Kim et al., 2014b), reducing a likelihood of 
obtaining a mosaic phenotype in regenerated plantlets. RGEN RNPs are 
also rapidly degraded by endogenous proteinase in cells, which might 
reduce the off-target effects induced by RGENs (Kim et al., 2014b). In 
this study, I found that targeted mutagenesis was achieved in 
regenerated plantlets at a high frequency of 46% and most of 
genome-edited plantlets contained bi-allielic mutations at the target site 
(14 of 16 mutants), indicating that delivery of RGEN RNP might be an 
effective tool for multiplex genome editing in plants.
One difficulty with generating a genome-edited plant with 
delivery of RGEN RNP is the optimization process for regenerating 
whole plants from protoplasts. In this study, I used cell-wall removed 
protoplasts as a starting material for PEG-mediated transfection. 
Protoplasts are generally suitable for delivery of biomolecules into plant 
cells, but are fragile because the rigidity of plant cells is highly 
sensitive to turgor pressure in case of cell wall-removed condition. 
Further studies are needed to test whether other sources such as callus 
can be used as a starting material for RGEN RNP-mediated genome 
editing. 
Improving the RGEN RNP-mediated genome editing system 
more efficient in plant cells is another important issue, because 
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handling a lot of callus derived from RGEN RNP-transfected cells is 
laborious and time-consuming. Recently, several groups reported that 
RGEN RNP-mediated genome editing with a chemically modified 
sgRNA could enhance the efficiency of targeted genome editing in 
human cells (Hendel et al., 2015; Rahdar et al., 2015). These studies 
showed that introducing chemical modifications such as 2’-O-mehtyl-3’ 
phosphorothioate and 2’-O-methyl 3’ thioPACE at the both termini of 
sgRNA yielded and enhanced genome editing efficiency at the target 
site. Plant genome editing with this method might be a good option for 
increasing the on-target indel rate. Chemical modification of RNAs also 
can be combined with currently characterized CRISPR-Cpf1 system 
(Zetsche et al., 2015a). CRISPR-Cpf1 system consists of Cpf1 nucleases 
and crRNAs. The length of crRNA is 43-nt, much shorter than that of 
sgRNA. This feature is advantageous for synthesizing and modifying the 
RNAs. 
In this study, I selected the BRASSINOSTEROID 
INSENSITIVE 2 (BIN2) gene for targeted mutagenesis in lettuce. In 
fact, this gene has been known having different phenotypes according 
to a type of mutation. BIN2-KO mutant showed enhanced tolerance to 
various abiotic stresses in rice (Koh et al., 2007), whereas missense 
mutation yielded a semi-dominant dwarf phenotype in Arabidopsis 
(Choe et al., 2002). I only generated BIN2 knock-out mutants by 
delivery of RGEN RNPs, but further studies are needed to develop a 
system enabling the genetic modification such as point mutation 
combined with the RNP delivery method for modeling of all the 
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genetic alterations found in plant systems. Recently, several groups 
independently reported the base editing systems enabling a single 
nucleotide editing without DNA DSBs at the target site with 
Cas9-deaminase fusion proteins (Hess et al., 2016; Komor et al., 2016; 
Ma et al., 2016; Nishida et al., 2016). DNA-free base editing that 
combines RNPs delivery with base editor might broaden the field of 
CRISPR-based plant genome editing in the near future
In summary, RGEN RNP delivery enables DNA-free genome 
editing in plant cells efficiently. Gene-edited plants are successfully 
regenerated from RGEN RNP-transfected protoplasts and mutant DNA 
sequences are stably transmitted to the next generation. I propose that 
this method might be an alternative for current GMO regulations and 
facilitate the usage of this tool in plant biotechnology and agriculture. 
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Chapter 2. Genome-wide analysis reveals 




The CRISPR-Cas (clustered regularly interspaced short 
palindromic repeats and CRISPR-associated proteins) system is an 
adaptive immune response in bacteria and archaea, which acts against 
foreign genetic elements (Barrangou et al., 2007; Horvath and 
Barrangou, 2010; Sorek et al., 2008; Sorek et al., 2013; Terns and 
Terns, 2011). In this system, CRISPR RNAs (crRNAs) guide cas 
effector proteins to the invading genetic elements in a sequence-specific 
manner, which yields silencing of foreign elements (Horvath and 
Barrangou, 2010). CRISPR-Cas systems consist of the three steps for 
the defense activity. First, short fragment of foreign DNA (protospacers) 
is integrated into the host genome at the end of the CRISPR array as 
known as adaptation process. Next, pre-crRNAs are transcribed from the 
CRISPR array and pre-crRNA is subjected to maturation, yielding 
processed crRNAs. Finally, crRNAs interact with a single Cas effector 
molecule or Cas protein complex, guide ribonuleoprotein complexes to 
the target substrates, and cleave target nucleic acids (Horvath and 
Barrangou, 2010).
CRISPR-Cas systems can be classified into two groups based 
on the format of Cas effector (Makarova and Koonin, 2015). Class 1 
systems which include CRISPR-Cas type I system (Hochstrasser et al., 
2014; Mulepati et al., 2014; Wiedenheft et al., 2011) and CRISPR-Cas 
type III system (Hale et al., 2014; Staals et al., 2014) harness crRNAs 
and Cas protein complexes composed of multi-components. On the other 
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hand, class 2 system, including CRISPR-Cas type II utilizes a processed 
crRNA and single effector protein such as the cas9 protein (Jinek et 
al., 2012). Of the CRISPR-Cas type II systems, CRISPR-Cas9 system 
derived from the pathogen Streptococcus pyogenes has been widely 
utilized for targeted genome engineering in human cells, mouse, model 
organisms, and plants (Cho et al., 2013a; Cho et al., 2013b; Cong et 
al., 2013; Hwang et al., 2013; Jiang et al., 2013; Jinek et al., 2013; Li 
et al., 2013; Mali et al., 2013; Nekrasov et al., 2013; Shan et al., 
2013; Sung et al., 2014; Wang et al., 2013). Cas9 protein induces 
DNA double-strand breaks (DSBs) at the chromosomal target site 
guided by gRNAs. This cleavage produces blunt DSBs that are repaired 
by endogenous repair mechanisms such as non-homologous end joining 
(NHEJ) and homologous recombination (HR) (Kim and Kim, 2014). 
Especially, error-prone NHEJ repair mechanism is predominant in 
eukaryotic cells (Shrivastav et al., 2008), yielding indels as a major 
pattern of RNA-guided genome editing. 
In a recent study, a new type of CRISPR Class 2 system has 
been identified in the bacterial genome, assigned to a type V system 
(Makarova et al., 2015). This system has different characteristics 
compared with type II CRISPR-Cas9 system (Zetsche et al., 2015a). 
First, this system contains a protein called Cpf1 (CRISPR from 
Prevotella and Francisella 1) and Cpf1 act as a single effector molecule 
instead of Cas9 protein. Second, pre-crRNAs are processed into the 
mature crRNAs without trans-activating crRNA (tracrRNA) (Deltcheva et 
al., 2011). Third, Cpf1-crRNA complexes recognize thymidine-rich DNA 
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sequence as a protospacer-adjacent motif (PAM) unlike Cas9 protein 
which recognizes the guanine-rich DNA sequence. Finally, CRISPR-Cpf1 
system cleaves target DNA, yielding staggered ends at the cleavage site 
unlike Cas9 protein, which produces blunt ends at the target site. 16 
Cpf1-family proteins were tested for targeted genome engineering in 
human cells, two of these derived from Acidaminococcus sp. BV3L6 
and Lachnospiraceae bacterium ND2006 showed a robust genome 
editing in HEK293T cells (Zetsche et al., 2015a). This result indicates 
that targetable site by CRISPR-endonucleases increases. Moreover, 
CRISPR-Cpf1 systems might facilitate a precise knock-in by directing 
the orientation of transgene fragment.
Despite these benefits, the application of the CRISPR-Cpf1 
system in genome-editing has been hampered by low on-target indel 
rates (Zetsche et al., 2015a) and a lack of studies evaluating a target 
specificity of Cpf1 nucleases. Especially, specificities of Cpf1 
endonucleases are a very important issue. Target specificity of Cpf1 
endonucleases is determined by 23-nucleotide length of guide sequence 
and there are hundreds of homologous sites that differ from the 
on-target sequence by up to 5-nt mismatches in the human genome. In 
case of CRISPR-Cas9, target specificity of RGEN has been studied by 
targeted analysis of predicted off-target sites based on sequence 
homology (Cho et al., 2014; Fu et al., 2013; Hsu et al., 2013) or 
unbiased methods (Frock et al., 2015; Kim et al., 2015; Tsai et al., 
2015). These studies found that RGEN tolerates mismatches between 
guide sequence of sgRNA and target DNA and theses effects are 
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dependent on the number of mismatches, distribution of mismatches, 
and the sequence context. In some case, DNA/RNA bulge obtained by 
sgRNA-Cas9 protein interaction caused off-target effects in the human 
genome (Kim et al., 2015). Based on these findings, several methods 
were suggested for reducing off-target effects (Cho et al., 2014; Fu et 
al., 2014; Guilinger et al., 2014; Kim et al., 2014b; Kleinstiver et al., 
2016; Slaymaker et al., 2016; Tsai et al., 2014). To utilize the potential 
of Cpf1, characterization of target specificities of CRISPR-Cpf1 
endonucleases in the human genome context might be necessary like 
SpCas9. 
Here, I optimize the Cpf1-mediated genome editing system in 
human cells and analyze the target specificity of Cpf1 endonucleases in 
the context of the human genome (Kim et al., 2016a). Cpf1 
endonucleases induce targeted genome modifications in human cells at a 
high frequency and are highly sensitive to mismatches in the 3’ PAM 
proximal region. These results suggest that CRISPR-Cpf1 endonuclease 




1. Cas9 and Cpf1 ribonucleoproteins
Recombinant Cas9 protein was purchased from ToolGen. 
SpCas9 sgRNAs and Cpf1 crRNAs were synthesized by in vitro 
transcription using T7 RNA polymerase as described previously. For 
preparation of recombinant Cpf1 proteins, the protein sequences were 
codon optimized for E.coli expression. Synthetic oligonucleotide 
fragments were cloned into bacterial protein expression vectors that 
encode 6xHis and maltose-binding protein tags (pMAL-c5x, New 
England BioLabs; and pDEST-hisMBP). The resulting expression 
vectors were used to transform Rosetta expression cells (EMD 
Millipore). 2 l of Luria broth (LB) growth medium with 50 mg/ml 
carbenicilin were inoculated with 10 ml overnight culture of Rosetta 
cells containing Cpf1 plasmids. Cells were cultured at 37 °C until 
OD600 reached 0.6, and then cooled to 16 °C before induction with 
0.5 mM IPTG for 14-18 h. Cells were then harvested and frozen at −
80 °C until protein purification. For protein purification, the cell pellet 
was lysed by sonication in 50 ml of lysis buffer (50 mM, HEPES pH 
7, 200 mM NaCl, 5 mM MgCl2, 1 mM DTT, 10 mM imidazole) 
supplemented with lysozyme (Sigma) and protease inhibitor (Roche 
complete, EDTA-free). The cell lysate was cleared by centrifugation at 
16,000g for 30 min, followed by passage through a syringe filter (0.22 
μm). The cleared lysate was applied to a nickel column (Ni-NTA 
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agarose, Qiagen), washed with 2 M salt, and eluted with 250 mM 
imidazole. The eluted protein solution was buffer exchanged and 
concentrated with lysis buffer without magnesium and imidazole. 
Purified Cpf1 proteins were examined with SDS-PAGE. Cpf1 protein 
activity was assessed by an in vitro cleavage assay.
2. Plasmids encoding Cpf1 and crRNAs
Cpf1-encoding vectors were obtained from Addgene. The Cpf1 
expression cassette was cloned into pcDNA3.1 backbone vector. Amino 
acid sequence of Cpf1 was human-codon optimized and CMV promoter 
was used for strong expression in human cells. The nuclear localization 
signal of nucleoplasmin and HA epitope were tagged at the C terminus 
of Cpf1 gene. crRNA-encoding vector was modified from pRG2-EXT 
vector which encodes sgRNA of SpCas9. crRNA vector was designed 
to human U6 promoter-driven transcription and poly-T signal was used 
for termination of crRNA transcription. Two BsmBI sites were inserted 
between 5’ repeat sequence of crRNA and poly-T signal for replacing 
guide sequence of crRNA. 
          
3. Cell culture and transfection conditions 
HEK293T/17 (ATCC, CRL-11268) cells were maintained with 
Dulbecco’s Modified Eagle’s Media (Welgene) supplemented with 10% 
FBS (Welgene) and 1% Antibiotics (Welgene). Cells were subcultured 
every two to three days. For Cpf1-mediated gene editing, 1.5 × 105 
55
cells were seeded into 24-well-plates before transfection. Next day, 
Cpf1 expression vector (500 ng) and crRNA-encoding vector (500 ng) 
were transfected into HEK293T17 cells using lipofectamine 2000 
(Invitrogen). Condition for liopfection was based on manufacturer's 
instructions. After 72 h post-transfection, cells were harvested and 
genomic DNA was purified with DNeasy Blood & Tissue Kit (Qiagen). 
4. Isolation of mutant clones 
For isolation of cpf1-mediated mutant clones, Hela (ATCC, 
CCL-2) cells was used. 8 × 104 cells were seeded into 24-well-plates 
before transfection and lipofection was performed using a protocol for 
HEK293T/17 cell transfection. Transfected cells were diluted and diluted 
cells were seeded into 96-well-plates at 0.3 cells/well condition. Single 
cell-derived clones were analyzed after two to three weeks.
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Results
1. Genome editing in human cells using Cpf1 system   
a. Optimization of Cpf1 system 
In the previous study, Cpf1 system showed a high success rate 
of gene modification at the randomly selected sites, but the efficiencies 
of Cpf1 nucleases were generally less than 10 %. (Zetsche et al., 
2015a). Before investigating a specificity of Cpf1 system, I optimized 
the condition for genome editing with Cpf1 nucleases in human cells. 
First, I performed the cell test with Cpf1 expression plasmids and 
crRNA-encoding amplicons as previously described. HEK293T/17 cells 
were seeded at 24-well plates and Cpf1 expression plasmids and 
crRNA-encoding amplicons were transfected into cells using 
lipofectamine 2000 next day. Several ratios of Cpf1 plasmid and 
crRNA-encoding amplicon were tested. Genomic DNA was isolated 72 
h post-transfection. Gene modification efficiencies were measured by 
T7E1 analysis. Both LbCpf1 and AsCpf1 showed on-target indel rates 
similar to those previously reported but, gene modification efficiencies 
were still low (Figure 13). 
To improve an efficiency of Cpf1 system, I designed a 
crRNA-encoding plasmid (Figure 14). Theoretically, circular plasmid 
DNA is more stable than PCR amplicon, as there are no ends from 
57
which degradation can easily occur by exonucleases in human cells. 
Moreover, PCR amplicon can induce transcription of incorrect RNA due 
to synthesis-failed oligonucleotide templates, potentially causing 
off-target DNA cleavages at sites harboring an RNA bulge (Kim et al., 
2016b). To verify an efficiency of Cpf1-mediated genome editing with 
crRNA-encoding plasmid, I transfected AsCpf1 expression plasmid and 
crRNA plasmid targeting the DNMT1-3 site. I measured the indel rates 
at the DNMT1-3 site by T7E1 assay and targeted deep sequencing and 
found that the highly efficient genome editing occurred at the 
DNMT1-3 site (Figure 15). To compare the efficiencies of 
Cpf1-mediated genome editing in HEK293T/17 cells transfected with 
either plasmids or PCR amplicons encoding crRNA directly, I chose 
three endogenous sites and performed the cell test. I found that the 
frequency of targeted mutagenesis increased by 2-30-fold at three 
endogenous target sites using crRNA plasmids rather than amplicons 
(Figure 16). To optimize genome editing efficiency and to avoid 
unwanted off-target effects at such sites, I used plasmids encoding 
crRNAs throughout the study. 
Next, I examined whether other Cpf1-family protein could be 
used for efficient genome editing in human cells with the optimized 
Cpf1 system. I additionally designed a crRNA-encoding plasmid for 
FnCpf1 and MbCpf1-mediated genome editing (Figure 17). FnCpf1 and 
MbCpf1 have been shown to be inefficient or inactive in human cells 
(Zetsche et al., 2015a), but I found that FnCpf1 and MbCpf1 could 
induce efficient genome editing at the endogenous sites with Cpf1 
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expression plasmids and crRNA-encoding plasmids. I further analyzed 
crRNA orthogonality with four Cpf1 orthologs from a Lachnospiraceae 
bacterium (LbCpf1), Acidaminococcus sp. (AsCpf1), Francisella novicida 
(FnCpf1) and Moraxella bovoculi 237 (MbCpf1). Cpf1 orthologs were 
co-transfected into HEK293T/17 cells with plasmids encoding crRNA 
orthologs in various combinations. Each Cpf1 ortholog was most 
efficient with its cognate crRNA. However, all four Cpf1 orthologs in 
combination with non-orthologonal crRNAs cleaved chromosomal target 
sites (Figure 17d). This result suggests that the Cpf1 protein is less 
sensitive to the difference in 5’ loop of crRNA and further engineering 
is necessary for orthogonal genome manipulation with four Cpf1 
orthologs. 
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Figure 13. Genome editing with Cpf1 plasmids and crRNA-encoding 
amplicon. Cpf1-mediated gene editing in HEK293T17 cells. Cpf1 
expression plasmid and crRNA-encoding PCR amplicon were transfected 
into cells using lipofectamine 2000 and genomic DNA was isolated 72 






Figure 14. DNA constructs for Cpf1-meidated genome editing. (a) 
Plasmid DNA constructs for Cpf1 expression. (b) Plasmid DNA 





Figure 15. Condition optimization of Cpf1-mediated genome editing. (a) 
Several dose conditions of Cpf1 expression plasmids and 
crRNA-encoding plasmids were tested. Targeted gene editing events 
were analyzed by the T7E1 assay. (b) Raw indel counts obtained from 
targeted deep sequencing analysis. 
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Figure 16. Comparison of crRNA delivery methods. crRNA-encoding 
plasmids or amplicons were used for Cpf1-mediated gene editing in 
three endogenous sites. Indel rates were analyzed by the T7E1 assay 







Figure 17. Genome editing using plasmids encoding Cpf1 orthologs and 
crRNAs. (a) Plasmid DNA constructs for FnCpf1 and MbCpf1 
expression. (b) Plasmid DNA constructs for hU6 promoter-driven Fn 
crRNA and Mb crRNA transcription. (c) Secondary structures of Fn 
crRNA and Mb crRNA. (d) crRNA orthogonality with four Cpf1 
orthologs. Plasmids encoding Cpf1 orthologs were co-transfected with 
plasmids encoding crRNAs, in various combinations, into HEK293T17 
cells. Indel rates were measured by targeted deep sequencing. Error 
bars indicate s.e.m.
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b. Isolation of mutant clones
To investigate whether Cpf1 system could be used for 
obtaining mutant clones, I transfected the DNMT1-3 targeting crRNA 
plasmids and Cpf1-encoding plasmids into Hela cells and carried out 
limiting dilution of transfected cells 72 h post-transfection and diluted 
cells were seeded at 96-well-plates. After 3 weeks, single cell-derived 
clones were genotyped by targeted deep sequencing. 6 of 13 clones for 
AsCpf1 and 4 of 28 clones for LbCpf1 contained mutant-alleles at the 
target sites (Figure 18), demonstrating that Cpf1-induced mutations were 





Figure 18. Isolation of Cpf1-mediated mutant clones. (a) DNA 
sequences of DNMT1-3 mutant clones obtained with AsCpf1. Hela cells 
were transfected with AsCpf1 expression plasmid and crRNA-encoding 
plasmid. Transfected cells were diluted and diluted cells were seeded at 
96-well plates. Genotypes of colonies were analyzed by targeted deep 
sequencing. PAM sequence is shown in bold and guide sequence is 
underlined. WT, wild-type. (b) DNA sequences of DNMT1-3 mutant 
clones obtained with LbCpf1.  
67
c. Comparison of the mutation frequencies obtained with 
Cpf1 and SpCas9
To compare the frequency of targeted mutations by AsCpf1, 
LbCpf1 and SpCas9, I chose ten chromosomal target sites which 
contained two PAM sequences, one recognized by Cpf1 (5’-TTTN-3’) 
and the other recognized by SpCas9 (5’-NGG-3’). Each RGEN had a 
wide range of mutation frequencies at these sites in HEK293T/17 cells 
(Table 5). SpCas9 was more efficient than Cpf1, with an average 
mutation rate of 32 ± 4%. LbCpf1 and AsCpf1 had mutation 
frequencies of 19 ± 6% and 20 ± 5% (Figure 19 and Table 5), 
respectively, which is about the same frequency at Staphylococcus 
aureus Cas9 (Ran et al., 2015). 
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Table 5. On-target activities of AsCpf1, LbCpf1 and SpCas9. Summary 
of on-target activities of AsCpf1, LbCpf1 and SpCas9 at 10 endogenous 
sites. Cpf1 PAM sequence is shown in bold and Cpf1 target sequence 
is shown in upper case. Cas9 PAM sequence is underlined. 
70
Figure 19. On-target indel rates obtained with AsCpf1, LbCpf1, and 
SpCas9 at 10 endogenous sites. Indel frequencies obtained with AsCpf1, 
LbCpf1 and SpCas9 at 10 endogenous sites. Cpf1 target sequence and 
SpCas9 target sequence were designed to be overlapped.
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2. Analysis of target specificity of Cpf1  
a. Analysis of target specificity of Cpf1 using 
mismatched crRNAs 
To verify the target specificity of Cpf1 in the context of 
mammalian genomes, I first investigated the effect of mismatches 
between guide sequence of the crRNA and target DNA systematically 
in human cells. AsCpf1 and LbCpf1 recognize and cleave 27-nucleotide 
target DNA sequences composed of the 5’-TTTN-3’ PAM sequence 
followed by the 23-nucleotide of protospacer sequence complementary 
to guide sequence of crRNA. I chose three endogenous target sites and 
carried out cell test with Cpf1 expression plasmids and crRNA-encoding 
plasmids which contained single or double nucleotide mismatches to the 
target DNA in the guide sequence of crRNA. The DNA cleavage 
efficiencies obtained with matched crRNA and mismatched crRNAs 
were measured by targeted deep sequencing (Figure 20). Strikingly, 
Cpf1 did distinguish single mismatches at position 1-17 and double 
mismatches at position 1-18 almost completely abolished DNA cleavage 
activities of Cpf1 for the DNMT1-4 site (Figure 20b). In general, Cpf1 
did tolerate single mismatches, whereas double mismatches at position 
1-18 led to a substantial loss of indel rates at three endogenous target 
sites. These results indicate that Cpf1 system works in human cells in 







Figure 20. Analysis of target specificity of Cpf1 with mismatched 
crRNAs. Indel frequencies obtained with mismatched crRNAs. Error 
bars indicate s.e.m. (a) DNMT1-3 target site. (b) DNMT1-4 target site. 
(c) AAVS1 target site.
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b. Genome-wide target specificity of Cpf1
To investigate the target specificity of Cpf1 nucleases in an 
unbiased manner, Digenome-seq (Kim et al., 2015; Kim et al., 2016b) 
was performed at the selected sites. Cell-free genomic DNA was 
digested with preassembled AsCpf1, LbCpf1 and SpCas9 
ribonucleoproteins (RNPs) and the digested genomic DNA was 
subjected to whole-genome sequencing (WGS). In general, WGS data 
produce random alignment of sequencing reads, but treatment of 
nucleases into genomic DNA in vitro leads to cutting of the on-target 
and potential off-target sites in the genome and these cleavages produce 
uniform alignments of sequencing reads at the cleaved sites. In vitro 
cleavage sites were computationally identified and DNA cleavage scores 
were calculated at each position. Cpf1 was highly specific based on the 
genome-wide Circos plots of DNA cleavage scores, cleaving 
chromosomal DNA in vitro at just 46 sites for the DNMT1-3 target 
site and one site for the DNMT1-4 target site (Figure 21). The number 
of in vitro cleavage sites identified in monoplex Digenome-seq analyses 
was 12 ± 5 for AsCpf1 or 6 ± 3 for LbCpf1, which is far less than 
the 90 ± 30 that was calculated with SpCas9 in a previous multiplex 
Digenome-seq experiment (Kim et al., 2016b) (Figure 22). 
Next, Digenome-captured sites were validated with targeted 
deep sequencing for measuring the DNA cleavage efficiencies at these 
sites in the context of human genomes and evaluating the sensitivity of 
Digenome-seq analysis. 46 sites were captured for the DNMT1-3 target 
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site, and only 4 sites showed the indel rates above basal sequencing 
errors (Figure 23). Indel rates of the most of the validated off-target 
sites were below 1%, much lower than those at corresponding on-target 
sites. Mismatches of the validated off-target sites were in the 3’ PAM 
distal region mostly. These results seem to be correlated with the 
results of mismatched crRNA test (Figure 20).
Notably, the OT6 off-target site harbored a non-canonical, 
5’-TCTN-3’ PAM sequence (Figure 23). This result suggests that Cpf1 
can cleave chromosomal target sites that contain non-canonical PAMs. 
To investigate a success rate of Cpf1-mediated genome editing at 
chromosomal target sites harboring non-canonical PAMs, I selected the 
target sites which contained non-canonical PAM sequences, such as 
5’-TTCN-3’ and 5’-TCTN-3’ and carried out the cell test. Success rates 
were calculated based on the number of target sites which showed indel 
rates above 1%. The success rate of Cpf1 mediated genome editing at 
the selected sites containing non-canonical PAMs was approximately 
50%, while Cpf1 showed 100% of targeting at the sites harboring 
canonical 5’-TTTN-3’ PAM (Figure 24). The targeted sites also showed 
an overall low indel rates, compared with the indel rates of the target 
sites harboring canonical PAM sequences. These results indicate that 
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Figure 21. Genome-wide Circos plots of DNA cleavage scores obtained 
with AsCpf1, LbCpf1 and SpCas9. Hela genomic DNA was digested 
with AsCpf1, LbCf1 and SpCas9 and whole genome sequencing (WGS) 
was performed for digested genomic DNA samples. In vitro cleavage 
sites obtained by nuclease treatment were captured through bioinformatic 
analysis of WGS data and DNA cleavage scores were calculated based 
on WGS raw data. Genome-wide Circos plots show DNA cleavage sites 
and DNA cleavage scores for each sample. (a) Genome-wide Circos 
plots for the DNMT1-3 target site. Red arrow indicates false positive. 
The asterisk indicates the position of on-target site. (b) Genome-wide 
Circos plots for the DNMT1-4 target site.
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(by Daesik Kim in Seoul National University)
Figure 22. The number of in vitro cleavage site. The number of 
Digenome-seq captured sites were calculated using monoplex 
Digenome-Seq with LbCpf1 (n=8), AsCpf1 (n=8), and SpCas9 (n=2). 
Previous multiplex Digenome-Seq data for SpCas9 (n=11) were plotted 
at the right side. 
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Figure 23. Validation of in vitro cleavage sites by targeted deep 
sequencing. Digenome-captured sites were validated by targeted deep 
sequencing. Two sites for LbCpf1 and four sites for AsCpf1 were 
validated with true off-target sites for DNMT1-3 crRNAs. PAM 
sequence is shown in bold and mismatched nucleotides are shown in 






Figure 24. Cpf1-mediated gene editing at target sites containing 
non-canonical PAM sequences. (a) Cpf1-mediated gene editing at 10 
endogenous sites containing 5’-TTCN PAM. Indel rates were measured 
by targeted deep sequencing. (b) Cpf1-mediated gene editing at 10 
endogenous sites containing 5’-TCTN PAM. (c) Cpf1-mediated gene 
editing at 10 endogenous sites containing 5’-CTTN PAM. 
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c. Analysis of target specificity of Cpf1 using truncated 
crRNAs
In the previous study, SpCas9 showed an improvement of 
specificity of nucleases with truncated gRNAs (Fu et al., 2014). To test 
whether truncated crRNA also could reduce indel rates of validated 
off-target sites, I designed a series of truncated crRNAs (Figure 25a) 
and carried out cell test. Indel rates of the on-target site and the 
off-target sites were measured by targeted deep sequencing. I found that 
crRNAs truncated at the 3’end enabled an up to ninefold reduction of 
indel frequencies at certain off-target sites (Figure 26b). Unfortunately, 
this approach is limited, as most off-target sites harbor mismatches at 




Figure 25. Analysis of target specificity of Cpf1 with truncated 
crRNAs. (a) Design for truncated crRNA. (b) Each truncated crRNA 
and full-length crRNA for DNMT1-3 target sites were transfected into 
HEK293T17 cells with AsCpf1-encoding plasmids. Indel rates of 
on-target site and validated off-target sites were analyzed by targeted 
deep sequencing. Specificity indicates on-target indel rate over off-target 
indel rate. Error bars indicate s.e.m. PAM sequence is shown in blue 
and mismatched nucleotides are shown in red and lower case. 
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Discussion
In the recent research, CRISPR-Cpf1 system, a putative type V 
CRISPR-Cas9 system was identified and this system was successfully 
repurposed for targeted genome editing in human cells (Zetsche et al., 
2015a). Cpf1 system consists of two components – Cpf1 protein and 
crRNA-, and target specificity of Cpf1 system is determined by 
23-nucleotides of guide sequence. These traits make CRISPR-Cpf1 
system as a simple platform for targeted genome engineering in human 
cells, model organisms, and plants like CRISPR-Cas9 system derived 
from Streptococcus pyogenes. Despite its potentials, target specificities 
of Cpf1 endonucleases have not been elucidated thoroughly, leaving a 
question about the off-target issue. To address this question, I optimized 
the platform for Cpf1-mediated genome editing in human cells and 
analyzed the target specificity of Cpf1 endonucleases. At the optimized 
condition, Cpf1 can induce targeted genome modification efficiently and 
Cpf1 shows a high sensitivity about the mismatches between guide 
sequence of crRNA and target DNA in human cells, suggesting that 
Cpf1 endonuclease is suitable for a precise genome editing. 
Improving the programmable nucleases for reducing off-target 
effects is a major goal of the field of genome engineering. In the 
clonal level, off-target effects of programmable nucleases are usually 
negligible (Kim et al., 2015; Park et al., 2015; Suzuki et al., 2014), 
because indel rates of off-target sites are generally lower than those of 
on-target sites and clone samples that harbor the genetic modifications 
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at the off-target sites can be easily excluded from a further research by 
manual handling. But, off-target effects can be a big problem in the 
case of biomedical applications of these technologies. For examples, ex 
vivo cell therapy needs a large number of genome-corrected cells for 
transplantation and a little portion of these cells that might contain the 
genetic modifications at the off-target sties can yield concerns about the 
safety issue. Recently, several groups independently reported the 
rationally engineered Cas9 variants to address this concern (Kleinstiver 
et al., 2016; Slaymaker et al., 2016). These studies demonstrate that 
Cas9 variants engineered by modification of the residues of SpCas9 
interacting with non-target DNA strand (Slaymaker et al., 2016) or 
target DNA strand (Kleinstiver et al., 2016) show reduced off-target 
effects compared to those obtained with wild-type SpCas9 and robust 
on-target cleavages. Although I did not directly compare the target 
specificity of Cpf1 endonuclease with that of Cas9 variants in this 
study, Cpf1 endonuclease has a potential for showing better 
performance than eSpCas9 and SpCas9-HF. First, mismatched crRNA 
test showed that double mismatches at position 1-18 led to substantial 
loss of DNA cleavage activity of wild-type Cpf1 and even single 
mismatches caused a loss of DNA cleavage activity of Cpf1 for the 
DNMT1-4 site. Second, Cpf1 generally showed the number of 
Digenome-captured sites, fewer than being present in wild-type Cas9 
nuclease. These results indicate that wild type of Cpf1 endonuclease 
generally shows a high specificity compared with wild type of SpCas9 
and it can be further improved by rational engineering of Cpf1 protein 
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based on the crystal structure information or delivery of Cpf1 nucleases 
as a preassembled, recombinant Cpf1 ribonucleoproteins (Dong et al., 
2016; Gao et al., 2016; Hur et al., 2016; Kim et al., 2014b; Yamano 
et al., 2016)
Cpf1-endonucleases recognize the 5’-TTTN-3’ as a PAM 
sequence, which might limit a broad use of this nuclease for correcting 
mutations related with human diseases because long PAM sequence 
restricts a design of target sites at the desired site. To harness the 
potential of Cpf1-endonuclease fully, engineering of PAM specificity of 
Cpf1 nuclease will be of vital importance in the near future. In recent 
studies, PAM specificity of SpCas9 and SaCas9 was successfully 
engineered using a directed evolution and E.coli-based selection system 
(Kleinstiver et al., 2015a; Kleinstiver et al., 2015b). With this method 
or other approaches, Cpf1 variants, which recognize the non-canonical 
PAM efficiently will be identified and expand the utility of this system 
in gene therapy. I found that wild-type of Cpf1 could recognize and 
cleave the target sites harboring non-canonical PAMs such as 
5’-TTCN-3’ and 5’-TCTN-3’ although success rate and gene 
modification efficiency were remarkably low. Improving the success rate 
and gene modification efficiency of Cpf1 at the target sites that contain 
these PAM sequences is worth a try in the first place. 
Efficient delivery of programmable nucleases is also a major 
issue in in vivo gene therapy. In case of in vivo delivery, recombinant 
adeno-associated virus (rAAV) is clinically used as a vector because of 
low cytotoxicity and low possibility of integrating of viral genome into 
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the human genome randomly. AAV has a packaging capacity of ~ 4.7 
kb, hampering the efficient packaging of Cpf1 expression cassette owing 
to the relatively large genetic size of Cpf1. Splitting of Cpf1 nuclease 
might be a good approach for facilitating the packaging of expression 
cassette and the increasing the efficiency of in vivo genome editing and 
epi-genome editing (Chew et al., 2016; Truong et al., 2015; Wright et 
al., 2015; Zetsche et al., 2015b).
In summary, CRISPR-Cpf1 demonstrates efficient genome 
editing in human cells and shows that this nuclease induces targeted 
genome modification in a highly specific manner. Thus, CRISPR-Cpf1 
will be a good option for RNA-guided genome editing and broaden the 
usages of this programmable nuclease in basic research, biotechnology, 
and biomedical research. 
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국문 초록
유전자 가위를 이용한 유전체 교정은 생명 과학 연구 분야
에서 필수적인 기술이다. 가장 많이 사용되고 있는 유전자 가위로
zinc-finger nucleases (ZFNs), transcription activator-like effector 
nucleases (TALENs), RNA-guided engineered nucleases (RGENs)이 있
고, 그중에서 RGENs은 guide RNA의 서열을 바꾸는 것으로 표적을
자유롭게 결정할 수 있는 편리성으로 최근 주목받고 있다.  
이번 연구에서는 Cas9 단백질과 guide RNA 복합체를 식물
원형질체에 polyethylene glycol (PEG)를 이용해 직접 전달하여 높은
효율로 식물 유전체를 교정하였고, 교정된 세포로부터 개체를 확보
할 수 있었다. 해당 방식은 plasmid DNA 대신 세포 내에서 빨리 작
동하고 분해되는 Cas9 단백질과 guide RNA 복합체를 사용했기 때문
에 RGENs의 오작동 가능성을 줄일 수 있었고, 유전자 교정 식물 관
련 규제로부터 벗어날 수 있는 가능성이 높을 것으로 기대된다.   
또한, 최근에 새롭게 보고된 CRISPR-Cpf1 시스템의 표적 특이성을
분석하였다. CRISPR-Cpf1 시스템은 인간 배양세포에서 효율적으로
유전체 교정을 수행하면서, 매우 특이적으로 표적 위치에 DNA 
DSBs를 일으키는 것을 확인할 수 있었다. 이러한 결과를 바탕으로
CRISPR-Cpf1이 매우 정교한 유전자 가위 형태임을 확인할 수 있었
다. CRISPR-Cpf1은 기존의 유전자 가위 기술이 표적할 수 있는 영
역을 확장시키는 데 중요한 역할을 할 것으로 기대된다.
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